TY  - GEN
AU  - Park,Kyung Woo
AU  - Lee,Joo Myung
AU  - Kang,Si-Hyuck
AU  - Ahn,Hyo-Suk
AU  - Kang,Hyun-Jae
AU  - Koo,Bon-Kwon
AU  - Rhew,Jay Young
AU  - Hwang,Sun Ho
AU  - Lee,Sung Yoon
AU  - Kang,Tae Soo
AU  - Kwak,Choong Hwan
AU  - Hong,Bum-Kee
AU  - Yu,Cheol Woong
AU  - Seong,In-Whan
AU  - Ahn,Taehoon
AU  - Lee,Han Cheol
AU  - Lim,Sang Wook
AU  - Kim,Hyo-Soo
TI  - Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus
SN  - 1876-7605
PY  - 2015///0130
KW  - Aged
KW  - Cardiovascular Agents
KW  - administration & dosage
KW  - Chi-Square Distribution
KW  - Coronary Angiography
KW  - Coronary Artery Disease
KW  - diagnosis
KW  - Diabetes Mellitus, Type 1
KW  - complications
KW  - Diabetes Mellitus, Type 2
KW  - Diabetic Angiopathies
KW  - Drug-Eluting Stents
KW  - Everolimus
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Kidney Failure, Chronic
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Myocardial Infarction
KW  - etiology
KW  - Patient Selection
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Propensity Score
KW  - Proportional Hazards Models
KW  - Prosthesis Design
KW  - Registries
KW  - Republic of Korea
KW  - Risk Factors
KW  - Sirolimus
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jcin.2013.12.201
ER  -